Literature DB >> 15671812

Chronic hepatitis C in HIV-infected patients: low eligibility and applicability of therapy with pegylated interferon-alpha plus ribavirin.

Andri Rauch, Martin Egger, Jürg Reichen, Hansjakob Furrer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15671812     DOI： 10.1097/01.qai.0000148535.97081.72

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN： 1525-4135            Impact factor:   3.731


× No keyword cloud information.
  12 in total

Review 1.  Hepatitis infection in the treatment of opioid dependence and abuse.

Authors:  Thomas F Kresina; Diana Sylvestre; Leonard Seeff; Alain H Litwin; Kenneth Hoffman; Robert Lubran; H Westley Clark
Journal:  Subst Abuse       Date:  2008-04-28

2.  Treatment for hepatitis C virus genotype 1 infection in HIV-infected individuals on methadone maintenance therapy.

Authors:  Lynn E Taylor; Sarah E Bowman; Stacey Chapman; Nickolas Zaller; Michael D Stein; Patricia A Cioe; Michaela A Maynard; Barbara Hedgis McGovern
Journal:  Drug Alcohol Depend       Date:  2010-12-21       Impact factor: 4.492

3.  Patient and provider characteristics associated with the decision of HIV coinfected patients to start hepatitis C treatment.

Authors:  Karen Chan Osilla; Glenn Wagner; Jeffrey Garnett; Bonnie Ghosh-Dastidar; Mallory Witt; Laveeza Bhatti; Matthew Bidwell Goetz
Journal:  AIDS Patient Care STDS       Date:  2011-08-08       Impact factor: 5.078

4.  Treat early or wait and monitor? A qualitative analysis of provider hepatitis C virus treatment decision-making in the context of HIV coinfection.

Authors:  Glenn Wagner; Gery Ryan; Karen Chan Osilla; Laveeza Bhatti; Matthew Goetz; Mallory Witt
Journal:  AIDS Patient Care STDS       Date:  2009-09       Impact factor: 5.078

5.  Factors that influence an HIV coinfected patient's decision to start hepatitis C treatment.

Authors:  Karen Chan Osilla; Gery Ryan; Laveeza Bhatti; Matthew Goetz; Mallory Witt; Glenn Wagner
Journal:  AIDS Patient Care STDS       Date:  2009-12       Impact factor: 5.078

6.  Hepatitis C patients' self-reported adherence to treatment with pegylated interferon and ribavirin.

Authors:  J J Weiss; L Bhatti; D T Dieterich; B R Edlin; D A Fishbein; M B Goetz; K Yu; G J Wagner
Journal:  Aliment Pharmacol Ther       Date:  2008-08-01       Impact factor: 8.171

7.  Provider and patient correlates of provider decisions to recommend HCV treatment to HIV co-infected patients.

Authors:  Glenn Wagner; Karen Chan Osilla; Jeffrey Garnett; Bonnie Ghosh-Dastidar; Laveeza Bhatti; Mallory Witt; Matthew Bidwell Goetz
Journal:  J Int Assoc Physicians AIDS Care (Chic)       Date:  2012-05-07

8.  Patient Characteristics Associated with HCV Treatment Adherence, Treatment Completion, and Sustained Virologic Response in HIV Coinfected Patients.

Authors:  Glenn Wagner; Karen Chan Osilla; Jeffrey Garnett; Bonnie Ghosh-Dastidar; Laveeza Bhatti; Matthew Bidwell Goetz; Mallory Witt
Journal:  AIDS Res Treat       Date:  2011-10-26

9.  Incident Hepatitis C Virus Infections in the Swiss HIV Cohort Study: Changes in Treatment Uptake and Outcomes Between 1991 and 2013.

Authors:  Gilles Wandeler; Marion Schlauri; Marie-Eve Jaquier; Janine Rohrbach; Karin J Metzner; Jan Fehr; Juan Ambrosioni; Matthias Cavassini; Marcel Stöckle; Patrick Schmid; Enos Bernasconi; Olivia Keiser; Luisa Salazar-Vizcaya; Hansjakob Furrer; Andri Rauch; V Aubert; M Battegay; E Bernasconi; J Böni; H C Bucher; C Burton-Jeangros; A Calmy; M Cavassini; G Dollenmaier; M Egger; L Elzi; J Fehr; J Fellay; H Furrer; C A Fux; M Gorgievski; H Günthard; D Haerry; B Hasse; H H Hirsch; M Hoffmann; I Hösli; C Kahlert; L Kaiser; O Keiser; T Klimkait; R Kouyos; H Kovari; B Ledergerber; G Martinetti; B Martinez de Tejada; K Metzner; N Müller; D Nadal; D Nicca; G Pantaleo; A Rauch; S Regenass; M Rickenbach; C Rudin; F Schöni-Affolter; P Schmid; J Schüpbach; R Speck; P Tarr; A Telenti; A Trkola; P Vernazza; R Weber; S Yerly
Journal:  Open Forum Infect Dis       Date:  2015-03-25       Impact factor: 3.835

10.  The Impact of HCV Infection Duration on HIV Disease Progression and Response to cART amongst HIV Seroconverters in the UK.

Authors:  Jamie Inshaw; Clifford Leen; Martin Fisher; Richard Gilson; David Hawkins; Simon Collins; Julie Fox; Ken McLean; Sarah Fidler; Andrew Phillips; Sam Lattimore; Abdel Babiker; Kholoud Porter
Journal:  PLoS One       Date:  2015-07-30       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.